Cellectis S.A.

NASDAQ:CLLS

Biotechnology

Healthcare
$1.06 -0.65%

-$0.02 today

Market cap
$106.78M
Beta
2.75
P/E (TTM)
-4.6
EPS (TTM)
-$0.67
52W Low $1.35High $5.48

Volume 0.02M

Average 0.04M

Price history

Cellectis S.A. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-74.21%

Period high

$5.35

Period low

$0.93

Latest

$1.06

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
6-KNov 13, 2026Nov 13, 2026
6-KNov 12, 2026Nov 12, 2026
SC 13D/ANov 9, 2026Nov 9, 2026
6-KNov 9, 2026Nov 9, 2026
6-KOct 28, 2026Oct 28, 2026
6-KSep 14, 2026Sep 14, 2026
6-KSep 11, 2026Sep 11, 2026
6-K/ASep 11, 2026Sep 11, 2026
6-KSep 1, 2026Sep 1, 2026
S-8Aug 6, 2026Aug 6, 2026
6-KAug 6, 2026Aug 6, 2026
6-KAug 6, 2026Aug 6, 2026
6-KJul 30, 2026Jul 30, 2026
6-K/AJun 26, 2026Jun 26, 2026
6-KJun 25, 2026Jun 25, 2026

Competitors

Who does Cellectis S.A. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CLLS's filings, answered from its disclosures.

What is the latest CLLS filing?

The latest filing shown is 6-K dated Nov 13, 2026.

How many recent filings does CLLS have?

Intrinsic Alpha currently shows 20 recent filings for CLLS.